Disc Medicine (IRON) Interest & Investment Income (2020 - 2026)

Disc Medicine (IRON) has reported Interest & Investment Income for 7 consecutive years, with $6.5 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Interest & Investment Income fell 7.44% year-over-year to $6.5 million; the TTM figure through Jun 2026 stood at $27.2 million (up 4.25% YoY), while the FY2025 annual figure was $27.8 million, up 30.38% from the prior year.
• Interest & Investment Income eased to $6.5 million in Q2 2026 per IRON's latest filing, from $6.9 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $7.4 million in Q4 2025 and bottomed at $7000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $4.3 million across 5 years, with a median of $4.8 million in 2023.
• Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 33714.29% — and 2026, when it declined 7.44%.
• Disc Medicine's Interest & Investment Income stood at $388000.0 in 2022, then jumped by 1105.41% to $4.7 million in 2023, then advanced by 24.82% to $5.8 million in 2024, then increased by 26.96% to $7.4 million in 2025, then dropped by 11.87% to $6.5 million in 2026.
• Business Quant data shows IRON's Interest & Investment Income at $6.5 million in Q2 2026, $6.9 million in Q1 2026, and $7.4 million in Q4 2025.